Skip to content

Evaluation of a Novel Portable Capnograph (MARIE) in Adult Postoperative Patients

Evaluation of a Novel Portable Mainstream Capnograph MARIE in Adult Postoperative Patients - A Prospective Feasibility Study

Status
Completed
Phases
Unknown
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT07178236
Acronym
NOVOCAP-Postop
Enrollment
40
Registered
2025-09-17
Start date
2025-09-22
Completion date
2025-12-22
Last updated
2026-01-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Anesthesia, Capnography, Monitoring, Postoperative Care, Respiration Rate Detection, Surgery

Keywords

capnography, Postoperative, surgery, anaesthesia, monitoring, respiration, novel equipment

Brief summary

Postoperative respiratory complications are common and sometimes hard to detect early. Desaturation is a late sign of reduced minute ventilation, especially if the patient is on supplemental oxygen, and measurement of arterial or endtidal CO2 will rapidly detect a reduction in minute ventilation. Capnography offers a non-invasive and continuous measure of end-tidal expiratory pressure of carbon dioxide (EtCO2). Capnography is not a standard in postoperative care but rather quite rare. In the present study we evaluate a novel portable capnography device, MARIE, in postoperative patients. 1. The primary outcome is to describe the correlation of end-tidal CO₂ (EtCO₂) measurements between MARIETM (Oxlantics Medical) and Philips Intelli Vue X3 Microstream. 2. Secondary outcomes include 1. Correlation between PaCO₂ and EtCO₂ measured by MARIE and Philips Intelli Vue X3 Microstream, respectively. 2. Time trajectories of PaCO₂ and EtCO₂ measured using MARIE and Philips Intelli Vue X3 Microstream, respectively 3. The overall agreement between the EtCO2 measured by MARIE and Philips Intelli Vue X3 Microstream and PaCO2 4. Respiratory rate measured by MARIE compared to manual counting and Philips Intelli Vue X3. 5. Comparison of oxygen flow by MARIE and the rotameter. 6. Comfort as reported by patient. 7. Usability as reported by nurse. 8. Reasons for premature termination of MARIE 9. Registration of technical problems, for example unexpected shut downs and blockage by mucus. MARIE will be applied immediately after tracheal extubation after surgery. CO2 values from MARIE will be compared to EtCO2 and PaCO2 derived from capnography equipment routinely used in the hospital and blood gas analysis, at set intervals in the postoperative ward. Respiratory rate will be compared to our standard care monitors, ie Philips Intelli Vue X3, alongside manual counting. Rate of oxygen delivery, when applicable, will also be compared to the rotameter.

Interventions

DEVICEMARIE

Portable capnoghraphy

Sponsors

Malin Jonsson Fagerlund
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
OTHER
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

1. Adult, ≥18 years of age 2. Elective surgery under general anesthesia 3. Planned for over night postoperative care

Exclusion criteria

1. Tracheostomy 2. Nasal obstruction 3. Rhino- or oral surgery 4. Not able to understand study information or signing consent form

Design outcomes

Primary

MeasureTime frameDescription
The primary endpoint is correlation of end-tidal CO₂ (EtCO₂) measurements between MARIETM (Oxlantics Medical) and Philips Intelli Vue X3 MicrostreamFrom enrolment to discharge from the postoperative unit or maximum 24 hoursEnd-tidal CO₂ (EtCO₂) measurements will be measured by MARIE (Oxlantic Medical AB) and Philips Intelli Vue X3 Microstream at several occasions and thereafter correlated

Secondary

MeasureTime frameDescription
Correlation between PaCO₂ and EtCO₂ measured by MARIE and Philips Intelli Vue X3 Microstream, respectively.From enrolment in the study until discharge from the postoperative unit or maximum 24 hoursMeasurement of arterial PCO₂ and EtCO₂ measured by MARIE and Philips Intelli Vue X3 Microstream at the same time will be done repeatedly and thereafter correlated
Time trajectories of PaCO₂ and EtCO₂ measured using MARIE and Philips Intelli Vue X3 Microstream, respectivelyFrom enrolment until discharge from the postoperative unit or maximum of 24 hoursArterial PCO₂ and EtCO₂ measured using MARIE and Philips Intelli Vue X3 Microstream will be measured repeatedly and thereafter correlated
The overall agreement between the EtCO2 measured by MARIE and Philips Intelli Vue X3 Microstream and PaCO2From enrolment until discharge from the postoperative unit or a maximum of 24 hoursEtCO2 measured by MARIE and Philips Intelli Vue X3 Microstream and PaCO2 will be collected simultaneously and repeatedly and thereafter investigated
Respiratory rate measured by MARIE compared to manual counting and Philips Intelli Vue X3From the enrolment in the study and until discharge from the postoperative unit or a maximum of 24 hoursRespiratory rate measured by MARIE compared to manual counting and Philips Intelli Vue X3 will be measured simultaneously and thereafter compared and correlated
Comparison of oxygen flow by MARIE and the rotameterFrom enrolment in the study until discharge from the postoperative unit or a maximum of 24 hoursOxygen flow rate by MARIE and the rotameter will be documented repeatedly and simultaneously and thereafter compared and correlated
Comfort as reported by patient as VAS (0-10).Three times/24 hours from admission to the postoperative unit until discharge from the postoperative unit or maximum 24 hoursComfort by the patient will be scored by the patient three times/24 hours on average Visual Analogue Scale from 1-10. 0= Worst comfort, 10= Comfortable
Usability as reported by nurse as VAS (0-10).From the time of enrolment until discharge from the postoperative unit of maximum 24 hoursThe nurse will score the usability on a Visual Analogue Scale (VAS) from 0-10. 0=Very low usability, 10=very high usability
Reasons for premature termination of MARIEFrom the enrolment to the discharge from the postoperative unit or a maximum of 24 hoursReport of reasons for premature termination

Countries

Sweden

Contacts

PRINCIPAL_INVESTIGATORMalin Jonsson Fagerlund, Professor

Karolinska University Hospital & Karolinska Institutet

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026